Genelux Corporation
Clinical trials sponsored by Genelux Corporation, explained in plain language.
-
Virus therapy tested to fight lung cancer that stops responding to treatment
Disease control Recruiting nowThis study is for people with advanced non-small cell lung cancer that has started to grow again after their first treatment with immunotherapy and chemotherapy. It compares a new two-part treatment—first a specially engineered virus given by IV, followed by standard chemotherapy…
Phase: PHASE2 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Mar 17, 2026 13:08 UTC
-
Virus therapy trial offers new hope for tough ovarian cancers
Disease control Recruiting nowThis study is testing if a modified virus called Olvi-Vec, given directly into the abdomen, can help chemotherapy work better for women with ovarian cancer that has stopped responding to standard platinum drugs. Participants will be randomly assigned to receive either the virus f…
Phase: PHASE3 • Sponsor: Genelux Corporation • Aim: Disease control
Last updated Mar 04, 2026 15:30 UTC